Patient survival in non-landmark and 2-month landmark analyses according to cohort. Event-free (A) and overall (B) survival of patients from time of diagnosis in non-landmark analyses. Event-free (C) and overall (D) survival of patients in landmark analyses from 2 months after diagnosis. Dx, diagnosis.